PFGIA
VIR icon

Patriot Financial Group Insurance Agency’s Vir Biotechnology VIR Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,400
Closed -$113K – 2247
2021
Q2 		$113K Hold
2,400
– – 0.02% 583
2021
Q1 		$123K Buy
+2,400
New +$129K 0.03% 499

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.44B AUM 23.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Patriot Financial Group Insurance Agency's VIR Position: Q3 2021 in Review

Patriot Financial Group Insurance Agency sold out of Vir Biotechnology (VIR) in Q3 2021, closing a stake of 2,400 shares — an estimated $113K sold.

Patriot Financial Group Insurance Agency first reported a position in VIR in Q1 2021 and held it in 2 quarters. The position peaked at $123K in Q1 2021. 175 funds tracked by Wall St. Rank hold VIR as of Q3 2021.

  • Patriot Financial Group Insurance Agency reported no remaining Vir Biotechnology position as of Q3 2021 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 2,400 Vir Biotechnology shares in Q3 2021, an estimated $113K.
  • Patriot Financial Group Insurance Agency first reported a position in Vir Biotechnology in Q1 2021 and held it in 2 quarters.
  • Patriot Financial Group Insurance Agency's Vir Biotechnology position peaked at $123K in Q1 2021.
  • 175 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2021.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2021, filed 24 Nov 2021.